 Rajratan Global Wire Ltd Q2FY26 consolidated net profit increases to Rs. 20.55 crores
Rajratan Global Wire Ltd Q2FY26 consolidated net profit increases to Rs. 20.55 crores Xchanging Solutions Ltd Q2 FY2026 consolidated PAT climbs to Rs. 16.26 crores
Xchanging Solutions Ltd Q2 FY2026 consolidated PAT climbs to Rs. 16.26 crores Cipla Ltd consolidated Q2FY26 net profit increases to Rs. 1351.17 crores
Cipla Ltd consolidated Q2FY26 net profit increases to Rs. 1351.17 crores Bhansali Engineering Polymers Ltd Q2 FY2025-26 net profit at Rs. 40.45 crores
Bhansali Engineering Polymers Ltd Q2 FY2025-26 net profit at Rs. 40.45 crores Valiant Communications Ltd Q2 FY2026 consolidated profit at Rs. 5.26 crores
Valiant Communications Ltd Q2 FY2026 consolidated profit at Rs. 5.26 crores 
              Bombay Stock Exchange has announced that effective from July 18, 2007, the equity shares of Sun Pharma Advanced Research Company Ltd (Scrip Code: 532872) are listed and admitted to dealings on the Exchange in the list of 'B1' Group Securities.
BSE has fixed the Base Price as Rs.72.65 and circuit filter will be 20%.
The equity shares of Sun Pharma Advanced Research Company Limited (Symbol: SPARC) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. July 18, 2007. Trading shall be in the Normal Market segment - Compulsory Demat (Rolling Settlement) for all investors.
The ISIN No. of the company is INE232I01014.